Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [RNA-Seq]

ABSTRACT: Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [RNA-Seq]

PROVIDER: PRJNA1069072 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR27730530_1.fastq.gz	Fastqsanger.gz
	SRR27730530_2.fastq.gz	Fastqsanger.gz
	SRR27730531_1.fastq.gz	Fastqsanger.gz
	SRR27730531_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 75

Similar Datasets

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes

Project description:Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes

| PRJNA1069066 | ENA

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes

Project description:Derepression of transposable elements (TE) by epigenetic therapy leads to the activation of immune response in cancer cells. However, the molecular mechanism of TE regulation by distinct chromatin modifier enzymes (CME) in context of p53 is still elusive. Here, we used FDA-approved epigenetic drugs to systematically inhibit distinct CMEs in p53 wild-type and p53-mutant colorectal, esophageal, and prostate cancer cells. We show that distinct TE subfamilies are derepressed by inhibition of different CMEs in cell type-specific manner. Co-inhibition of DNMT and HDAC (DNMTi-HDACi) had the most consistent effect across cancer types. Loss of p53 results in stronger TE activation and TE-chimeric transcript expression and this effect is largely mediated by the non-genomic actions of p53. Robust immune response elicited by DNMTi-HDACi is due to induced inverted repeat Alu expression concomitant with reduced ADAR1-mediated Alu RNA editing. Collectively, our systematic analyses provide insights for rational use of epigenetic therapies in distinct cancers.

2025-06-16 | GSE254244 | GEO

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [ChIP-Seq]

Project description:Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [ChIP-Seq]

| PRJNA1069071 | ENA

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [RNA-Seq]

2025-06-16 | GSE254242 | GEO

Cancer cell type-specific derepression of transposable elements by inhibition of chromatin modifier enzymes [ChIP-Seq]

Project description:The combination of epigenetic and immunotherapy is emerging as a promising approach for cancer therapy. Derepression of transposable elements (TE) by epigenetic drugs leads to activation of immune response. However, the molecular mechanism of TE regulation by distinct chromatin modifier enzymes (CME) in context of p53 is still elusive. Here, we used FDA-approved epigenetic drugs to systematically inhibit distinct CMEs in p53 wild-type and p53-mutant colorectal, esophageal, and prostate cancer cells. We show that distinct TE subfamilies are derepressed by inhibition of different CMEs in cell type-specific manner. Co-inhibition of DNMT and HDAC (DNMTi-HDACi) had the most consistent effect across cancer types. Loss of p53 results in stronger TE activation and TE-chimeric transcript expression and this effect is largely mediated by the non-genomic actions of p53. Robust immune response elicited by DNMTi-HDACi is due to induced inverted repeat Alu expression concomitant with reduced ADAR1-mediated Alu RNA editing, whereas SETDB1 inhibition activates ADAR1 expression. Collectively, our systematic analyses provide insights for rational use of epigenetic therapies in distinct cancers.

2025-06-16 | GSE254243 | GEO

Transposable Elements in Frontotemporal Lobar Degeneration

Project description:Transposable Elements in Frontotemporal Lobar Degeneration

| PRJNA561866 | ENA

Transposable Elements in Frontotemporal Lobar Degeneration

Project description:Transposable Elements in Frontotemporal Lobar Degeneration

| PRJNA561865 | ENA

Transposable elements study for Fritillaria imperialis

Project description:Transposable elements study for Fritillaria imperialis

| PRJEB104641 | ENA

Transposable elements function as mechanical sensors [HiCAR]

Project description:Transposable elements function as mechanical sensors [HiCAR]